Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults
Launched by SUN YAT-SEN UNIVERSITY · Apr 9, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether taking a combination of certain vitamins and nutrients can help lower high levels of homocysteine in the blood. Homocysteine is an amino acid, and having too much of it can be a risk factor for heart problems. The study will include Chinese adults who have homocysteine levels above 10 μmol/L. They will be giving participants supplements that include folic acid, vitamin B6, vitamin B12, and betaine, to see if these can effectively reduce homocysteine levels.
To be eligible for this study, participants must be between 18 and 65 years old and have homocysteine levels between 10 and 100 μmol/L. It's important that they haven't taken any supplements or medications that could lower their homocysteine for at least a month before joining the trial. The study is open to all genders, and participants will be required to sign a consent form agreeing to take part in the research. If you're interested in helping with this study, it could be a chance to contribute to understanding how to manage homocysteine levels better!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 18 - 65 years;
- • 2. Concentration of plasma homocysteine is between 10 and 100 μmol/L;
- • 3. Free from any supplements or drugs that may decrease plasma homocysteine concentration for at least 1 month prior to the beginning of study;
- • 4. Willing to participate in the study and sign informed consent.
- Exclusion Criteria:
- • 1. Pregnant or lactating women;
- • 2. Allergic physique or allergic to our compound nutrients tablets;
- • 3. Complicated with severe diseases;
- • 4. Unable to conduct study procedures;
- • 5. Participating in any other intervention studies.
About Sun Yat Sen University
Sun Yat-sen University, a prestigious institution located in Guangzhou, China, is dedicated to advancing medical research and healthcare innovations. As a leading clinical trial sponsor, the university leverages its extensive academic resources and collaboration with top-tier medical professionals to conduct rigorous clinical studies. Committed to improving patient outcomes and contributing to global health knowledge, Sun Yat-sen University focuses on a wide range of therapeutic areas, employing cutting-edge methodologies to ensure the integrity and efficacy of its research initiatives. Through its clinical trials, the university aims to foster scientific advancements and enhance the quality of care provided to patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Huilian Zhu, professor
Study Chair
Sun Yat-sen University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported